Caxton Associates (New York)’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,419
Closed -$495K 526
2024
Q3
$495K Sell
3,419
-5,444
-61% -$743K 0.02% 363
2024
Q2
$1.29M Buy
+8,863
New +$1.24M 0.04% 212
2023
Q3
Sell
-3,613
Closed -$406K 443
2023
Q2
$406K Buy
+3,613
New +$431K 0.06% 299
2021
Q4
Sell
-5,888
Closed -$845K 573
2021
Q3
$845K Sell
5,888
-3,605
-38% -$495K 0.09% 121
2021
Q2
$1.11M Buy
9,493
+3,157
+50% +$311K 0.12% 63
2021
Q1
$510K Buy
+6,336
New +$483K 0.05% 157
2019
Q2
Sell
-8,523
Closed -$219K 414
2019
Q1
$219K Buy
+8,523
New +$233K 0.03% 323

Other funds holding CROX

Caxton Associates (New York)'s CROX Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Crocs (CROX) in Q4 2024, closing a stake of 3,419 shares — an estimated $495K sold.

Caxton Associates (New York) first reported a position in CROX in Q1 2019 and held it in 7 quarters. The position peaked at $1.29M in Q2 2024. 496 funds tracked by Wall St. Rank hold CROX as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Crocs position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,419 Crocs shares in Q4 2024, an estimated $495K.
  • Caxton Associates (New York) first reported a position in Crocs in Q1 2019 and held it in 7 quarters.
  • Caxton Associates (New York)'s Crocs position peaked at $1.29M in Q2 2024.
  • 496 funds tracked by Wall St. Rank held Crocs as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.